4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
LB Pharmaceuticals Inc (LBRX) operates in the Biotechnology industry and is headquartered in New York, United States with about 35 employees. Its market capitalization is roughly $901 million. In the fiscal year ended 2025-12-31, LBRX reported $0M in revenue and ($25M) in net income.
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($30M) | ($65M) | ($11M) | ($3M) |
| Net Income | ($25M) | ($63M) | ($6M) | ($14M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($22M) | ($14M) | ($5M) | ($5M) | ($6M) |
| Net Income | ($19M) | ($12M) | ($4M) | ($5M) | ($5M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $313M | $34M | $46M | $22M |
| Total Liabilities | $12M | $128M | $80M | $50M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LBRX viewer.
About TickerBase · Data methodology & sources